4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Jaguar Health, Inc. (JAGX) operates in the Biotechnology industry and is headquartered in San Francisco, United States with about 47 employees. Its market capitalization is roughly $6 million. In the fiscal year ended 2025-12-31, JAGX reported $12M in revenue and ($53M) in net income.
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health.
Interactive charts & full statements → Open the JAGX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $12M | $12M | $10M | $12M | — |
| Gross Profit | $8M | $10M | $8M | $10M | — |
| Operating Income (EBIT) | ($45M) | ($31M) | ($34M) | ($34M) | — |
| Net Income | ($53M) | ($38M) | ($41M) | ($48M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $20M | $3M | $3M | $3M | $2M | — |
| Gross Profit | $19M | $1M | $3M | $2M | $2M | — |
| Operating Income (EBIT) | $10M | ($20M) | ($7M) | ($8M) | ($9M) | — |
| Net Income | $9M | ($23M) | ($10M) | ($10M) | ($10M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $38M | $53M | $51M | $48M | — |
| Total Liabilities | $57M | $47M | $46M | $49M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive JAGX viewer.
About TickerBase · Data methodology & sources